NCT07107815View on ClinicalTrials.gov

A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics

Enrolling by invitationOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

Rectal Cancer, Adenocarcinoma

Trial Locations (1)

100021

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors

lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER